Clinical trials
Recruiting Multiple Myeloma trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2014 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 6 |
| 2022 | 9 |
| 2023 | 10 |
| 2024 | 7 |
| 2025 | 12 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 61 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 8 |
| AbbVie | 4 |
| Assistance Publique - Hôpitaux de Paris | 4 |
| University Hospital, Toulouse | 4 |
| AstraZeneca | 3 |
| Pfizer | 3 |
| Regeneron Pharmaceuticals | 3 |
| GlaxoSmithKline | 2 |
| Hoffmann-La Roche | 2 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 61 |
| Hematologic Neoplasms | 5 |
| Recurrence | 5 |
| Leukemia | 3 |
| Lymphoma | 3 |
| Neoplasms | 3 |
| Neoplasms, Plasma Cell | 3 |
| Leukemia, Myeloid, Acute | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
Trials
Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.